Title: Development of a recombinant influenza vaccine Flublok®
Speaker: Manon Cox, ISV President / NextWaveBio
Moderator: Indresh Srivastava, Vice President, Vaccine Development Novavax
This event has passed.
The ISV is a global not-for-profit organization that aims to encourage, establish, and promote the development and use of vaccines to prevent and control infectious and non-infectious diseases in animals and humans.